FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
FDA grant seeks research to reduce nitrosamine impurities in drugs, ensuring public safety and continued access to needed medications, with a plan for sustained research.
The Repurposing Generic (ReGen) Drugs Evidence Package Challenge from NIH Challenges seeks strong scientific evidence for generic drugs as affordable treatments for costly diseases.
This grant seeks to develop AI/ML models using real-world data to monitor clinical outcomes when patients switch between complex generics and brand-name drugs.
This grant funds centers that provide specialized research services and training to external investigators in areas related to NIDDK’s mission, such as obesity and diabetes, to enhance research rigor and efficiency.